HPV Infection in Squamous Cell Carcinoma of the Hypopharynx, Larynx, and Oropharynx With Multisite Involvement
暂无分享,去创建一个
Y. Oda | Hidetaka Yamamoto | R. Yasumatsu | Takahiro Hongo | Takashi Nakagawa | Rina Jiromaru | K. Hashimoto | M. Matsuo | R. Kuga | Midori Taniguchi
[1] Y. Oda,et al. High-risk HPV-related Squamous Cell Carcinoma in the Conjunctiva and Lacrimal sac , 2022, The American journal of surgical pathology.
[2] A. Psyrri,et al. De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma , 2021, Viruses.
[3] J. Lack,et al. TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers , 2021, Nature Medicine.
[4] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[5] T. Nakano,et al. p16 overexpression and Rb loss correlate with high‐risk HPV infection in oropharyngeal squamous cell carcinoma , 2021, Histopathology.
[6] M. Masuda,et al. Clinicopathologic Significance of EGFR Mutation and HPV Infection in Sinonasal Squamous Cell Carcinoma , 2020, The American journal of surgical pathology.
[7] R. Franco,et al. Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV , 2020, Infectious Agents and Cancer.
[8] K. Pienta,et al. CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies , 2020, Clinical Cancer Research.
[9] M. Masuda,et al. HPV-related Sinonasal Carcinoma , 2019, The American journal of surgical pathology.
[10] K. Greven,et al. Human papillomavirus-associated squamous cell carcinoma of the larynx or hypopharynx: Clinical outcomes and implications for laryngeal preservation. , 2019, Oral oncology.
[11] J. Merker,et al. Comparative Performance of High-Risk Human Papillomavirus RNA and DNA In Situ Hybridization on College of American Pathologists Proficiency Tests. , 2019, Archives of pathology & laboratory medicine.
[12] J. Gartner,et al. T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] H. Hirakawa,et al. High-risk type human papillomavirus infection and p16 expression in laryngeal cancer , 2019, Infectious Agents and Cancer.
[14] Young Uk Kim,et al. Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer: A Phase 2 Clinical Trial , 2019, JAMA oncology.
[15] E. Sturgis,et al. Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Carol Colasacco,et al. Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists. , 2017, Archives of pathology & laboratory medicine.
[17] Armen Khararjian,et al. Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective , 2017, The American journal of surgical pathology.
[18] M. Poljak,et al. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. , 2016, Journal of the National Cancer Institute.
[19] T. Nakano,et al. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma. , 2016, Human pathology.
[20] P. Delvenne,et al. Carcinogenic HPV infection in the cervical squamo‐columnar junction , 2015, The Journal of pathology.
[21] S. Altekruse,et al. Human Papillomavirus Prevalence in Invasive Laryngeal Cancer in the United States , 2014, PloS one.
[22] J. Ordi,et al. High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas , 2014, Modern Pathology.
[23] A. Psyrri,et al. Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] J. Bishop,et al. Human Papillomavirus-related Carcinomas of the Sinonasal Tract , 2013, The American journal of surgical pathology.
[25] Xiao-Jun Ma,et al. Detection of Transcriptionally Active High-risk HPV in Patients With Head and Neck Squamous Cell Carcinoma as Visualized by a Novel E6/E7 mRNA In Situ Hybridization Method , 2012, The American journal of surgical pathology.
[26] W. Westra. The Morphologic Profile of HPV-Related Head and Neck Squamous Carcinoma: Implications for Diagnosis, Prognosis, and Clinical Management , 2012, Head and Neck Pathology.
[27] J. Flanagan,et al. Transcriptionally‐active high‐risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas – a tissue microarray study utilizing E6/E7 mRNA in situ hybridization , 2012, Histopathology.
[28] A. El‐Naggar,et al. p16 expression as a surrogate marker for HPV‐related oropharyngeal carcinoma: A guide for interpretative relevance and consistency , 2012, Head & neck.
[29] G. Nuovo,et al. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer , 2011, Modern Pathology.
[30] S. El-Mofty,et al. Human papillomavirus and oropharynx cancer: Biology, detection and clinical implications , 2010, The Laryngoscope.
[31] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[32] A. Shiotani,et al. Videolaryngoscopic Transoral En Bloc Resection of Supraglottic and Hypopharyngeal Cancers Using Laparoscopic Surgical Instruments , 2010, The Annals of otology, rhinology, and laryngology.
[33] Satoaki Nakamura,et al. Definitive radiotherapy for T1-2 hypopharyngeal cancer: a single-institution experience. , 2009, International journal of radiation oncology, biology, physics.
[34] Witold Zatonski,et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. , 2007, Journal of the National Cancer Institute.
[35] D. Wazer,et al. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. , 1996, Cancer research.
[36] W. Hong,et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. , 1991, The New England journal of medicine.
[37] P. Bradley,et al. Treatment Options for Hypopharyngeal Cancer. , 2019, Advances in oto-rhino-laryngology.